A promising approach for treatment of tumor-induced bone diseases: Utilizing bisphosphonate derivatives of nucleoside antimetabolites

American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer

Bruce E. Hillner, James N. Ingle, Rowan T. Chlebowski et al. · Journal of Clinical Oncology · 2003 · 973 citations

Medicine, Oncology, Bone Metabolism +11

A novel orthotopic model of breast cancer metastasis to bone

Maria Lelekakis, Jane M. Moseley, T. John Martin et al. · Clinical & Experimental Metastasis · 1999 · 436 citations

Medicine, Cancer Biology, Oncology +13

Bisphosphonates induce apoptosis in human breast cancer cell lines

S G Senaratne, Grisha Pirianov, Janine Mansi et al. · British Journal of Cancer · 2000 · 424 citations · Full text

Medicine, Oncology, Pharmacology +17

Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound

Jonathan R. Green, Klaus Müller, Knut A. Jaeggi · Journal of Bone and Mineral Research · 1994 · 420 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

Michael Gnant, Brigitte Mlineritsch, G. Luschin-Ebengreuth et al. · The Lancet Oncology · 2008 · 397 citations

Medicine, Oncology, Pharmacotherapy +17